Innoviva (INVA) Current Leases (2019 - 2026)
Innoviva's (INVA) quarterly Current Leases came in at $646000.0 in Q1 2026, down 49.53% YoY from $1.3 million in Q1 2025, and up 54.55% on a QoQ basis from $418000.0 in Q4 2025.
Innoviva (INVA) Current Leases (2019 - 2026) Analysis & Trends
Innoviva (INVA) has 5 years of Current Leases data on file, last reported at $646000.0 in Q1 2026.
- Quarterly Current Leases fell 49.53% year-over-year to $646000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $646000.0 (down 49.53% YoY) and the FY2025 annual result came in at $418000.0, down 73.41% from the prior year.
- Current Leases rose to $646000.0 in Q1 2026, from $418000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.6 million in Q4 2024 to a low of $418000.0 in Q4 2025.
- A 4-year average of $1.0 million and a median of $1.1 million in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases soared 30.24% — and 2025, when it sank 73.41%.
- Tracing INVA's Current Leases over 4 years: stood at $1.2 million in 2023, then soared by 30.24% to $1.6 million in 2024, then slumped by 73.41% to $418000.0 in 2025, then surged by 54.55% to $646000.0 in 2026.
- The last three Current Leases figures came in at $646000.0 (Q1 2026), $418000.0 (Q4 2025), and $680000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | 712,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 712,000.00 |
| Mar 31, 2026 | 646,000.00 |
| Dec 31, 2025 | 418,000.00 |
| Sep 30, 2025 | 680,000.00 |
| Jun 30, 2025 | 983,000.00 |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Jun 30, 2019 | 317,000.00 |
| Mar 31, 2019 | 308,000.00 |